Ln-101 Gene Therapy for Muscle Growth and Recovery
Ln-101 plays a key role in muscle hypertrophy, repair, and vascularization. Our gene therapy delivers Ln-101 selectively to skeletal muscle via systemic injection, activating local growth without elevating systemic hormone levels - not affecting the heart contrary to the status quo.
Gene therapy for muscle growth and trauma recovery with demonstrated rapid hypertrophy
58% of military injuries are musculoskeletal, with no fast, hormone free or cold chain independent way to treat it. Current recovery strategies are ineffective, and tend to degrade overall warfighter health. Ln-101 supports pre-deployment conditioning, accelerating muscle trauma recovery time and augments muscle mass. Its dual-use nature also offers faster recovery than is currently available to civilians.
Future applications in spaceflight and prolonged immobilization. Sarcopenia/Aging (population): 45 Million Americans. Post surgery recovery: 30 million Americans. U.S. Sports Med: $8.24 Billion (by 2026) TAM. 20 million Americans also targeting Injured Athletes.
